MoEFCC invites comments on Draft Liquid Waste Management Rules, 2024; prescribes duties and obligations of various entities regarding generation and disposal of liquid waste
The Ministry of Forest, Environment and Climate Change (“Ministry”) has invited public comments on...
RBI amends Master Direction – Reserve Bank Of India (Regulatory Framework for Microfinance Loans) Directions, 2022
The Reserve Bank of India (“RBI”) has amended the Master Direction - Reserve Bank Of India...
RBI directs PSPs to review their payment systems / devices in terms of accessibility to Persons with Disabilities; action plan to be submitted by 11th November, 2024
The Reserve Bank of India (“RBI”) has issued guidelines on ‘Facilitating accessibility to digital...
Union Health Ministry mandates registration of Clinical Research Organizations under New Drugs and Clinical Trials Amendment Rules, effective 1st April, 2025
The Union Health Ministry has notified the New Drugs and Clinical Trials (Amendment) Rules, 2024...
Pharmaceuticals Department notifies revisions to sub-scheme ‘Revamped Pharmaceutical Technology Upgradation Assistance Scheme’: Increases incentive cap and simplifies application process for Pharma MSMEs
Department of Pharmaceuticals has notified modifications under the sub-scheme "Revamped...
CDSCO mandates online-only submissions in Form-44 for veterinary drugs through SUGAM portal, ending offline options
With a view to streamline the regulatory submission procedure, the veterinary division of the...
CDSCO invites public comments on Draft Guidelines for Good Clinical Practices till 12th October 2024
The Central Drugs Standard Control Organization (“CDSCO”) has invited comments/suggestions on...
NPPA revises ceiling price of Chloroquine (150mg) tablet price to Rs. 1.33 per tablet; manufacturers directed to align pricing with ceiling price
The National Pharmaceutical Pricing Authority ("NPPA"), after reviewing the Wholesale Price Index...
Centre notifies Uniform Code for Marketing Practices in Medical Devices 2024; mandates annual self-declarations on Code adherence and disclosure of expenses on medical education/conferences and free samples through UCPMP portal
The Department of Pharmaceuticals has notified the Uniform Code for Marketing Practices in Medical...
Pharmaceutical companies mandated to disclose free sample and continuing medical education /conference related expenses on UCPMP portal within two months of financial year-end
The Department of Pharmaceuticals has directed pharmaceutical companies to submit a declaration...
Health Ministry prohibits the manufacture, sale or distribution of 156 Fixed Dose Combinations
The Ministry of Health and Family Welfare (MoHFW) has implemented an immediate ban on 156...
Health Ministry restricts the manufacture, sale or distribution of two Fixed Dose Combinations of Naproxen subject to certain conditions
The Ministry of Health and Family Welfare (“MoHFW”) has implemented restriction on the...